MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.360
+0.040 (3.03%)
Aug 4, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,865,274
Market Cap
82.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 0 | - |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -5 | -27.78% |
| Dec 31, 2022 | 18 | 9 | 100.00% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| PolyPid | 75 |
| Biomea Fusion | 40 |
| NeurAxis | 24 |
| Cognition Therapeutics | 14 |
| Atara Biotherapeutics | 13 |
| Rallybio | 9 |
| Alterity Therapeutics | 9 |
MAIA News
- 27 days ago - MAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion - TheFly
- 27 days ago - MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial - GlobeNewsWire
- 5 weeks ago - MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer - GlobeNewsWire
- 6 weeks ago - MAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial - TheFly
- 6 weeks ago - MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University - GlobeNewsWire
- 7 weeks ago - MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial - GlobeNewsWire
- 2 months ago - MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial - TheFly
- 2 months ago - MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial - GlobeNewsWire